All posts by CAC2

Guest Blog–Applications Open: 2025 HBF Inspiration Award for Early Career Investigators in Pediatric Brain Cancer

    Overview: Now in its 6th year, the Hopper-Belmont Foundation (“HBF”) Inspiration Award aims to motivate young investigators to make a difference early in their careers by providing a personal award recognizing concepts and/or projects in one of the following areas: Innovation: Recognition of an innovative idea in need of proof of concept/data prior to applying for larger grants from NIH or other funding resources Aspiration: Providing resources to begin or to further research in a designated HBF focus area This is a $5,000 award that can be used at the discretion of the winner, e.g. personal or research. […]

Read more

CAC2 Childhood Cancer Community News Digest (April 21-27)

Assorted News from the Last Week: Parents of kids with cancer fear GOP budget cuts could slash Medicaid What I wish I had known: A pediatric oncologist's transition to survivorship care The Food and Drug Administration (FDA) has granted breakthrough therapy designation to treatment with an investigational B7-H3 targeting autologous CAR-T cell therapy for pediatric patients with diffuse intrinsic pontine glioma. Researchers trained and validated a deep learning model that can detect subtle changes across post-treatment brain scans and forecast pediatric glioma recurrence with up to 89 percent accuracy. Living in a persistent-poverty neighborhood was associated with a higher risk [...] Read more

CAC2 Childhood Cancer Community News Digest (April 14-20)

Assorted News from the Last Week: CAC2 Individual Member Robert Dilley blogging about why sustained research funding is essential to progress. AACR issues calls to action to advocacy colleagues and supporters of NIH funding. NCI Annual Report to the Nation:  "Cancer death rates in children declined steadily over the study period; those for adolescents and young adults also declined until recently, when the decline slowed and stabilized." A new study suggests that early-life exposure to two widespread environmental pollutants -- small particle air pollution and outdoor artificial light at night -- could increase the risk of pediatric thyroid cancer. CT [...] Read more

CAC2 Webinar–“The Role of AI from Diagnosis to Treatment for Childhood Cancer”

In CAC2's April webinar, "The Role of AI from Diagnosis to Treatment for Childhood Cancer," our speakers explored how Artificial Intelligence is being used in pediatric cancer and how to harness the full potential on behalf of patients by enhancing diagnosis, treatment planning, and patient outcomes. Dr. Resnick spoke first and articulated how Artificial Intelligence (AI) will play a transformative role in pediatric cancer research by enhancing diagnosis, treatment planning, and patient outcomes. AI is being used to analyze complex datasets, improve the speed, provide new diagnostic capabilities, accuracy, and personalize treatment strategies, thereby creating new opportunities for children with [...] Read more

Guest Blog–AACR Issues Calls to Action to Advocacy Colleagues and Supporters of NIH Funding

Shared with permission from and thanks to the American Association for Cancer research. This post contains information about the “Rally for Medical Research ‘On the Road’” initiative, which probably could not be coming at a more important time based on all of the troubling and concerning news for medical research that seems to be reported on a daily basis. The most troubling of the news was reported last week when a leaked document showed that there may be plans for a 40 percent cut (a $20 billion cut) to NIH’s budget as part of the FY2026 White House budget request. […]

Read more

Member Blog–I Survived Leukemia Because of a Clinical Trial. Will Future Patients Be So Lucky?

By CAC2 Individual Member Robert Dilley writing about why sustained research funding is essential to progress. This essay first appeared on April 15 in MedPage Today. I don’t usually talk about my cancer diagnosis. But as a physician-scientist who survived leukemia at 18 years old and now cares for people facing their own cancer diagnoses, I feel compelled to share my story — because it speaks directly to what’s at stake in medicine today. The clinical trial that saved my life wouldn’t have existed without robust investment in biomedical research. And as debates over federal research funding continue, I think about […]

Read more

CAC2 Childhood Cancer Community News Digest (April 7-13)

Assorted News from the Last Week: A study explores the effects of identifying pediatric cancer survivors at risk for complications, developing targeted interventions, determining where and how to provide life-long risk-based care, and whether providing risk-based surveillance will mitigate the burden of morbidity and mortality among childhood cancer survivors. A proposed cancer survivorship model that involves interdisciplinary coordination and the use of digital tools has the potential to “move the outcomes needle.” Only half of adolescents and young adults with cancer get fertility counseling before treatment. Psychological empowerment interventions that are technology-based significantly improve the psychological well-being of parents of [...] Read more

CAC2 Childhood Cancer Community News Digest (March 31-April 6)

Assorted News from the Last Week: A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in chicken eggs and analyzing their proteins. The United States Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation for NEO100 (perillyl alcohol) in the treatment of pediatric-type diffuse high-grade gliomas. Adolescents and young adults (AYAs) (aged 13-39 years) represent a growing segment of the cancer population who face distinct challenges in receiving care, leading to adverse treatment experiences and stagnant survival outcomes. Preventable pediatric cancer mortality surges in areas of [...] Read more

CAC2 Childhood Cancer Community News Digest (March 24-30)

Assorted News from the Last Week: A man who battled childhood cancer has received the first known transplant of sperm-producing stem cells, in a study aimed at restoring the fertility of cancer's youngest survivors. Projections suggest that 45.6% of childhood cancer survivors would die before reaching 65 years of age, compared to 15.0% of the general population. Children constitute 7.2% of annual cancer cases in Nigeria. U.S. Senators Michael Bennet (D-Colo.) and Markwayne Mullin (R-Okla.) introduced the Give Kids a Chance Act, which would give children with cancer access to combination therapy trials. The bill will also incentivize pharmaceutical companies [...] Read more

CAC2 Childhood Cancer Community News Digest (March 17-23)

Assorted News from the Last Week: Data shows that childhood cancer survivors were much more likely to develop an aging-associated health condition before the age of 65, with earlier onset, compared with the general population, according to a modeling study. Nearly all cancer treatments for children pose some short- or long-term risk for development of cardiovascular disease and that pediatric patients with cancer may be especially vulnerable to cardiovascular disease because of young age at treatment and expected long life span afterward. Childhood cancer survivors were also at greater risk of developing melanoma. High costs among factors in Malaysia behind [...] Read more